{"id":"W2977980618","doi":"10.1097/01.hs9.0000563228.79887.e0","title":"PS1237 DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVOURABLE HODGKIN LYMPHOMA (CHL): RESULTS OF A PHASE II, PROSPECTIVE, MULTI‐CENTER STUDY BY FONDAZIONE ITALIANA LINFOMI","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Interim analysis; Vinblastine; Radiation therapy; Prospective cohort study; Surgery; Internal medicine; Nuclear medicine; Clinical trial; Chemotherapy; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003433998,0.0005659911,0.001052523,0.0001413229,0.0001347475,0.00007156749,0.0002161631,0.0002316326,0.0004149174],"category_scores_gemma":[0.0001373397,0.0004462807,0.0002647845,0.0005433388,0.00008702748,0.0003919748,0.000126163,0.0001766315,0.0002265283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005144957,"about_ca_system_score_gemma":0.0002395071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004230987,"about_ca_topic_score_gemma":0.001367557,"domain_scores_codex":[0.9966624,0.00009936087,0.0009942441,0.0009374162,0.0006322832,0.0006742502],"domain_scores_gemma":[0.9978772,0.0001690955,0.000386393,0.001061144,0.0002339129,0.0002722286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01742796,0.1074326,0.8410873,0.0002105278,0.001031357,0.001214252,0.008396124,0.00002095276,0.003761827,0.00006777106,0.005767873,0.01358144],"study_design_scores_gemma":[0.4525287,0.03095714,0.4403161,0.001144376,0.0002329367,0.00009558766,0.002980529,0.0003838115,0.05442929,0.00003628304,0.01596475,0.0009304941],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901932,0.002011111,0.000005923579,0.0004980091,0.0001764828,0.004446073,0.0003140569,0.00009330927,0.002261801],"genre_scores_gemma":[0.9747825,0.000606894,0.0002942881,0.0002412698,0.00006727602,0.0003436868,0.0001538674,0.00008852418,0.02342175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4351008,"threshold_uncertainty_score":0.9997989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01901969089911033,"score_gpt":0.3009490587376345,"score_spread":0.2819293678385242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}